Medical Procedure News

RSS

MOH approves BrainStorm's NurOwn stem cell therapy for Phase I/II clinical trial

BrainStorm Cell Therapeutics Inc. a leading developer of adult stem cell technologies and therapeutics, today announced that the Israeli Ministry of Health (MOH) has granted clearance for a Phase I/II clinical trial using the company's autologous NurOwn stem cell therapy in patients with amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig's Disease.

11 Oct 2010

TTF therapy with chemotherapy increases survival time in patients with non-small cell lung cancer

Novocure reported today that patients with advanced non-small cell lung cancer (NSCLC) achieved a significant increase in survival time when tumor treating fields (TTF) therapy was added to chemotherapy, as compared to previously reported outcomes for patients receiving chemotherapy alone.

11 Oct 2010

$Balloon kyphoplasty offers effective relief for debilitating spinal fractures suffered by metastatic cancer patients$

Balloon kyphoplasty offers effective relief for debilitating spinal fractures suffered by metastatic cancer patients

A surgical technique appears to offer quick and effective relief for debilitating spinal fractures often suffered by patients with metastatic cancer, researchers reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan.

11 Oct 2010

Lifestyle interventions benefit overweight, obese and severely obese adults

Lifestyle interventions, including physical activity and structured weight loss programs, can result in significant weight loss for overweight, obese and severely obese adults, according to two reports that were posted online today by JAMA. The studies and accompanying editorials were made available early online to coincide with the presentation of these papers at the 28th Annual Scientific Meeting of the Obesity Society. The articles will appear in the October 27 print issue of JAMA.

11 Oct 2010

Researchers identify factor that affects breast cancer patients' survival time in chemotherapy

In a study presented at the 35th Congress of the European Society for Medical Oncology (ESMO), Dr Giovanni Bernardo from Fondazione Maugeri in Pavia, Italy, presented results that suggested it may be possible to identify subsets of metastatic breast cancer patients who are likely to respond to subsequent lines of chemotherapy.

11 Oct 2010

Correcting vitamin D deficiency before orthopedic surgery improves patient outcome: Study

Almost 50 percent of patients undergoing orthopedic surgery have vitamin D deficiency that should be corrected before surgery to improve patient outcomes, based on a study by researchers at Hospital for Special Surgery (HSS) in New York City. Vitamin D is essential for bone healing and muscle function and is critical for a patient's recovery. The study appears in the October issue of The Journal of Bone and Joint Surgery.

8 Oct 2010

Pioneer launches Bigfoot ALIF implant for lumbar procedures

Pioneer Surgical Technology today announces the market launch of the Pioneer Advantage portfolio of allograft products including a large ALIF interbody, Bigfoot. Pioneer Advantage products include machined allografts for cervical and anterior lumbar procedures as well as demineralized strips and cubes for use in various spinal and general orthopaedic surgeries.

7 Oct 2010

Cs-131 brachytherapy seed implant can treat metastasized cancer

IsoRay, Inc. announced today another milestone in the use of Cesium-131 (Cs-131) brachytherapy seeds (internal radiation therapy). Doctors at a world renowned medical facility have performed the world's first Cs-131 brachytherapy seed implant following a wedge resection of a lung tumor which originated from a form of malignant uterine cancer. Initially used to treat primary cancers, Cs-131 seeds are now being used to treat metastasized cancer.

7 Oct 2010

Study shows radioembolisation with TheraSphere effective for primary liver cancer

MDS Nordion, a leading provider of products and services to the global health science market, today announced that the first large European study using Yttrium-90 (Y-90) glass microspheres has been published on the use of TheraSphere, an innovative radioembolisation therapy for the localised treatment of patients with advanced hepatocellular carcinoma (HCC) or primary liver cancer.

7 Oct 2010

Vivaglobin therapy effective for patients with primary immunodeficiency

Vivaglobin (subcutaneous immunoglobulin [IgG]) (SCIg) is an effective and safe initial therapy for treatment-naive patients with primary immunodeficiency (PI) and may offer an attractive alternative to intravenous IgG (IVIg) therapy in the newly diagnosed, according to data presented today at the XIVth Meeting of the European Society for Immunodeficiencies.

7 Oct 2010

Integra Total Wrist Fusion System to be featured at ASSH Annual Meeting

Integra LifeSciences Holdings Corporation announced today that it is featuring the Integra Total Wrist Fusion System at the 65th Annual Meeting of the American Society for Surgery of the Hand (ASSH) on October 7-9, in Boston, Massachusetts.

7 Oct 2010

New microtechnology approach may prevent pelvic autonomic nerve injury in rectal cancer surgical procedure

Surgeons in Germany have found that using microtechnology to elec-tronically stimulate and monitor pelvic autonomic nerves may help prevent problems after a surgical procedure for rectal cancer, such as bladder, urinary and fecal incontinence, and sexual function disorders, according to a study reported at the 2010 Annual Clinical Congress of the American College of Surgeons.

7 Oct 2010

Vitamin D deficiency may impact orthopaedic procedure outcomes

Forty-three percent of patients scheduled to undergo orthopaedic surgery have insufficient levels of vitamin D and two out of five of those patients had levels low enough to place them at risk for metabolic bone disease, according to a study published this month in the October 6th issue of the Journal of Bone and Joint Surgery (JBJS).

7 Oct 2010

'The Pittsburgh Protocol' enables reduction of multiple anti-rejection drugs after transplantation

The Pittsburgh Protocol is unique in utilizing bone marrow cells to enable reduction of the need for multiple anti-rejection drugs after transplantation. The University of Pittsburgh Medical Center is currently the only transplantation center in the world to offer it. An early report of the initial experience with the "Pittsburgh Protocol" in three recipients of upper extremity transplants was presented during the 2010 Annual Clinical Congress of the American College of Surgeons.

7 Oct 2010

Odd foreign bodies removed from patients

Sermo, the world's largest online community for physicians, today announced its weekly hot topic. Of over 200 physician respondents to an online poll and discussion, 85% said they have removed odd foreign bodies from patients.

6 Oct 2010

European infertility patients are limited in choice for medically assisted reproduction treatment

In a number of European countries, infertility patients are limited in their choice for medically assisted reproduction treatment, experts criticized today at the European Health Forum Gastein. Many patients seek treatment outside their home countries.

6 Oct 2010

Accuray announces 100,000th patient treated with CyberKnife Robotic Radiosurgery System

Accuray Incorporated, a global leader in the field of radiosurgery, announced today that the 100,000th patient has been treated with the CyberKnife® Robotic Radiosurgery System, a non-invasive alternative to surgery for the treatment of both cancerous and non-cancerous tumors anywhere in the body. One in four patients treated with CyberKnife radiosurgery received treatment during Accuray's fiscal 2010, which ran July 2009 to June 2010.

6 Oct 2010

Breast-Specific Gamma Imaging more effective than ultrasound in finding cancers

Results of a study on Breast-Specific Gamma Imaging (BSGI) presented at the annual breast meeting of the American Society of Clinical Oncology in Washington, D.C., showed that BSGI was nearly twice as effective in finding cancers and more than three times as likely to lead to the correct diagnosis when compared to ultrasound.

6 Oct 2010

LDR expands lumbar VerteBRIDGE platform

LDR, a total spine solution company, announced today the expansion of its lumbar VerteBRIDGE product offering following 2 years of successful clinical use of the ROI-A® ALIF Cage. The new applications offer a complete range of alternatives to currently adopted lateral approaches. The new direct lateral and oblique lumbar systems have been used successfully in Europe in more than 100 cases.

6 Oct 2010

Medtronic announces U.S. launch of VERTEX SELECT Reconstruction System Posted Screw Module

Medtronic, Inc. today announced the U.S. launch of the VERTEX SELECT® Reconstruction System Posted Screw Module. The announcement was made at the 25th Annual Meeting of the North American Spine Society (NASS) in Orlando, Fla.

6 Oct 2010

Medical Procedure News

MOH approves BrainStorm's NurOwn stem cell therapy for Phase I/II clinical trial

TTF therapy with chemotherapy increases survival time in patients with non-small cell lung cancer

Balloon kyphoplasty offers effective relief for debilitating spinal fractures suffered by metastatic cancer patients

Lifestyle interventions benefit overweight, obese and severely obese adults

Researchers identify factor that affects breast cancer patients' survival time in chemotherapy

Correcting vitamin D deficiency before orthopedic surgery improves patient outcome: Study

Pioneer launches Bigfoot ALIF implant for lumbar procedures

Cs-131 brachytherapy seed implant can treat metastasized cancer

Study shows radioembolisation with TheraSphere effective for primary liver cancer

Vivaglobin therapy effective for patients with primary immunodeficiency

Integra Total Wrist Fusion System to be featured at ASSH Annual Meeting

New microtechnology approach may prevent pelvic autonomic nerve injury in rectal cancer surgical procedure

Vitamin D deficiency may impact orthopaedic procedure outcomes

'The Pittsburgh Protocol' enables reduction of multiple anti-rejection drugs after transplantation

Odd foreign bodies removed from patients

European infertility patients are limited in choice for medically assisted reproduction treatment

Accuray announces 100,000th patient treated with CyberKnife Robotic Radiosurgery System

Breast-Specific Gamma Imaging more effective than ultrasound in finding cancers

LDR expands lumbar VerteBRIDGE platform

Medtronic announces U.S. launch of VERTEX SELECT Reconstruction System Posted Screw Module

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Latest News